Amongst adolescent and younger grownup (AYA) breast most cancers survivors, the cell well being intervention Younger, Empowered and Sturdy, or YES, was related to enhancements to normal and cancer-specific high quality of life and a discount in burdensome signs after six months, in accordance with analysis offered on the 2025 San Antonio Breast Most cancers Symposium (SABCS).
Findings from the YES medical trial confirmed that, amongst 360 breast most cancers survivors, at six months those that utilized YES (179 sufferers) reported a High quality of Life in Grownup Most cancers Survivors (QLACS) normal abstract rating of 77.6, in contrast with a rating of 78.1 amongst those that acquired standard care (181 sufferers). As detailed in a press launch issued Friday morning by the Dana-Farber Most cancers Institute, at baseline, the imply QLACS scores for normal and cancer-specific high quality of life had been 86.3 and 52.5 within the YES arm and 79.7 and 48.9 within the standard care arm, with larger QLACS scores point out poorer high quality of life.
By six months, imply QLACS scores for normal high quality of life had decreased by 8.7 factors within the YES arm and 1.6 factors for sufferers within the standard care arm, whereas imply cancer-specific high quality of life scores decreased by 7.8 factors within the YES arm and by 3 factors within the standard care arm.
“YES is a scalable [mobile] well being intervention that improved normal and cancer-specific high quality of life and lowered some burdensome signs at six months in our adolescent and younger grownup survivors,” mentioned Dr. Ann H. Partridge, founder and director of the Program for Younger Adults with Breast Most cancers at Dana-Farber Most cancers Institute, within the press briefing. “This represents a novel paradigm for supporting sufferers with out clinician involvement, for probably the most half, within the survivorship interval and thus it represents a really, doubtlessly scalable public well being effort for tougher to achieve populations who’re very, very busy, cannot get into the clinic and or cannot very simply entry the clinic.”
YES Research Design and Affected person Traits
Sufferers had been enrolled at three websites — Dana-Farber (190 sufferers), The Ohio State College (118 sufferers) and Columbia College Medical Middle (52 sufferers) — and, with a view to be eligible for the trial, needed to be feminine, age 15 to 39 on the time of being recognized with stage 0 to three breast most cancers, lower than three years from the tip of energetic remedy, don’t have any proof of breast most cancers recurrence and communicate English.
“Adolescents and younger adults with breast most cancers, these sufferers and survivors expertise substantial signs and considerations. … Past inflicting misery, these signs and considerations could affect longer-term selections, together with adherence to lifesaving adjuvant remedy and optimum well being behaviors and comply with up care and thereby influence not solely high quality of life, however illness and survival outcomes,” mentioned Partidge. “Serial monitoring, utilizing digital affected person reported outcomes or ePROs with clinician monitoring has improved outcomes for adults, predominantly these receiving chemotherapy or at later phases with superior most cancers.”
Sufferers had been a median of 18.9 months since analysis, and at analysis most — 171 sufferers, or 47.5% — had been age 35 to 39. Nearly all of sufferers — 290, or 80.6% — had been White and 320 sufferers, or 88.9%, lived in city areas. Most sufferers had stage 1 (124, or 34.8%) or stage 2 (135, or 38.2%) illness at analysis, had been ER/PR constructive (266, or 74.5%) underwent bilateral mastectomy (156, or 43.8%) and acquired chemotherapy/organic/immunotherapy (276, or 77.3%).
The YES portal entailed month-to-month digital patient-reported outcomes concerning signs, AYA considerations and assessments in addition to a chat room and a journal operate.
“The intervention was designed to have interaction and activate sufferers to self-manage signs and considerations, empowering them to contact their medical workforce for unmet wants or considerations or signs,” mentioned Patridge. “… The objective was to cut back emotions of isolation and scale back stress and thereby doubtlessly enhance our outcomes.”
References
- “Randomized managed trial of Younger, Empowered & Sturdy (YES), an mHealth intervention for adolescent and younger grownup breast most cancers survivors” by Dr. Ann H. Patridge, offered at: 2025 San Antonio Breast Most cancers Symposium; December 9-12, 2025; San Antonio, TX.
- “Cellular Well being Device Helps Enhance High quality of Life For Younger Breast Most cancers Survivors,” information launch, Dana-Farber Most cancers Institute, Dec. 12, 2025; https://www.dana-farber.org/newsroom/news-releases/2025/mobile-health-tool-helps-improve-quality-of-life-for-young-breast-cancer-survivors
For extra information on most cancers updates, analysis and schooling, don’t overlook to
